Novo Nordisk A/s

Caspar Christensen

Claus Ulrich Jessen

Rune Severinsen

Peter Madsen

Anders Klarskov Petersen

Jens Christian Norrild

Steffen Kidal

Henrik Valore

Jesper F Lau

Patrick William Garibay

Thomas Kruse

Tina Moeller Tagmose

Paw Bloch

Tina Møller Tagmose

Asser Sloth Andersen

Inga Sig Nielsen Nørby

Jan Lindy Sørensen

Michael Raunkjaer

Jesper Færgeman Lau

Jan Lindy Soerensen

Described is a dipeptide comprising a non-proteogenic amino acid, methods of making such and methods of using said dipeptide in a process of making a polypeptide or protein comprising one or more non-proteogenic amino acids.

Dipeptide comprising a non-proteogenic amino acid

A semi-recombinant method for the production of GLP-1 analogues and derivatives with non-proteogenic amino acids in the N-terminal part combining the use of recombinant expression techniques and chemical peptide synthesis.

Semi-recombinant preparation of GLP-1 analogues

A method for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.

Method of acylating a peptide or protein

A method has for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.

Growing community of inventors

Broenshoej, Denmark

Caspar Christensen